Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2
Author(s) -
David M. Whiley,
Namraj Goire,
Stephen B. Lambert,
Sanghamitra Ray,
E. Athena Limnios,
Michael D. Nissen,
T. P. Sloots,
John W. Tapsall
Publication year - 2010
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkq187
Subject(s) - mtrr , neisseria gonorrhoeae , ceftriaxone , cephalosporin , penicillin , penicillin binding proteins , microbiology and biotechnology , biology , sexually transmitted disease , antibacterial agent , spectinomycin , genetics , virology , allele , antibiotics , gene , syphilis , human immunodeficiency virus (hiv) , methylenetetrahydrofolate reductase
Reduced susceptibility to extended-spectrum cephalosporins in Neisseria gonorrhoeae has, to date, been associated with three alterations: a mosaic penA allele encoding the penicillin-binding protein 2 (PBP2); A-del-mtrR, an adenine deletion in the mtrR promoter; and penB, comprising mutated alleles of PorBIb. In this study, we examined an association between reduced susceptibility to ceftriaxone and additional mutations in gonococcal PBP2.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom